Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

IDE Group significantly reduces losses following cost cutting efforts

Mon, 11th Mar 2019 10:35

(Sharecast News) - IT services provider IDE Group cut costs during its last financial year, resulting in an improved performance in its second half.IDE made £7.2m worth of annualised staff cost reductions in 2018, with further reductions identified since the year-end bringing the total to £7.8m, and various other operational cost savings, including a reduction in costs associated to software licensing and property.The AIM-listed outfit also reached a settlement in relation to an outsourced service contract which will result in a further saving of around £3m over the next three years.As a result, the provision made at the time of IDE's interim results has been reversed, leading it to expect a "significantly reduced loss at adjusted EBITDA level for the full year."Elsewhere, IDE said it had made progress in relation to its cost base and saw several of its material customers renew a total of £3.6m of contracts towards the end of the year, some on a multi-year basis.As of 1030 GMT, IDE shares had shot up 20.37% to 1.62p.

Related Shares

More News
4 Nov 2022 20:38

TRADING UPDATES: SigmaRoc files patent; Griffin restarts operations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

26 Oct 2022 15:52

UK shareholder meetings calendar - next 7 days

30 Sep 2022 17:32

EARNINGS UPDATES: Harland & Wolff interim revenue climbs

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

29 Sep 2022 15:09

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

31 Aug 2022 21:41

TRADING UPDATES: ImmuPharma waits on FDA; IDE Group waits on audit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.